Kamonrattana, R., Sathitsamitphong, L., Choeyprasert, W., Charoenkwan, P., Natesirinilkul, R., & Fanhchaksai, K. (2020). A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients.

Kamonrattana, Ruchirek, Lalita Sathitsamitphong, Worawut Choeyprasert, Pimlak Charoenkwan, Rungrote Natesirinilkul, and Kanda Fanhchaksai. A Randomized, Open-labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/tazobactam Monotherapy in Comparison With Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. 2020.

Kamonrattana, Ruchirek, et al. A Randomized, Open-labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/tazobactam Monotherapy in Comparison With Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. 2020.